BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8912082)

  • 1. Molecular biology of human ovarian cancer.
    Chow SN; Chien CH; Chen CT
    Int Surg; 1996; 81(2):152-7. PubMed ID: 8912082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic alterations in the genesis and development of ovarian cancer].
    Okamoto A; Yokoyama S; Terashima Y
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in the ovary.
    Berchuck A
    J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and biologic factors in the pathogenesis of ovarian cancer.
    Berek JS; Martínez-Maza O
    J Reprod Med; 1994 Apr; 39(4):241-8. PubMed ID: 8040839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma.
    Kim JW; Kim HS; Kim IK; Kim MR; Cho EY; Kim HK; Lee JM; Namkoong SE
    Gynecol Oncol; 1998 Jun; 69(3):230-6. PubMed ID: 9648593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenes in ovarian cancer.
    Berchuck A; Kohler MF; Bast RC
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):813-27. PubMed ID: 1500387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay.
    Chien CH; Huang CC; Lin YH; Shen J; Chow SN
    Gynecol Oncol; 1997 Sep; 66(3):405-10. PubMed ID: 9299253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P; Russo J; Mgbonyebi OP; Russo IH
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.
    Rodriguez GC; Haisley C; Hurteau J; Moser TL; Whitaker R; Bast RC; Stack MS
    Gynecol Oncol; 2001 Feb; 80(2):245-53. PubMed ID: 11161867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular biology of ovarian cancer].
    Tanaka K
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2162-7. PubMed ID: 10635299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
    Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
    Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells.
    Oh HS; Moharita A; Potian JG; Whitehead IP; Livingston JC; Castro TA; Patel PS; Rameshwar P
    Cancer Res; 2004 Sep; 64(17):6327-36. PubMed ID: 15342422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.